| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f97b69af68b76c14e8778fda7a734a9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2020-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fbe76a9f051e8e35360f04c8ae31dbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8738ba5123ca4a9859c4912d0798dc32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74dde826e78fa310bdef55e1d2f4b47d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ff8feddf3205ece89b9f78dc80605a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f67cb9c0381acb11628a996750c25c23 |
| publicationDate |
2021-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202106703-A |
| titleOfInvention |
Cd80 variant proteins and uses thereof |
| abstract |
The present invention provides variant CD80 polypeptides with altered affinity for their homologous binding partners; and immunomodulatory fusion proteins comprising the variant CD80 polypeptides. The content of the present invention also provides pharmaceutical ingredients containing such polypeptides and/or proteins; and methods for regulating immune response and/or treating cancer, infectious diseases and/or immunological diseases. |
| priorityDate |
2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |